Yaghi Nasser K, Radu Stephanie, Nugent Joseph G, Mazur-Hart David J, Pang Brandi W, Bowden Stephen G, Murphy Blair, Han Seunggu J
Neurological Surgery, Oregon Health & Sciences University, Portland, Oregon, USA.
Radiation Medicine, Oregon Health & Sciences University, Portland, Oregon, USA.
Neurooncol Pract. 2022 Feb 2;9(2):133-141. doi: 10.1093/nop/npac007. eCollection 2022 Apr.
There is growing evidence supporting the need for a short time delay before starting radiotherapy (RT) treatment postsurgery for most optimal responses. The timing of RT initiation and effects on outcomes have been evaluated in a variety of malignancies, but the relationship remains to be well established for brain metastasis.
Retrospective study of 176 patients (aged 18-89 years) with brain metastases at a single institution (March 2009 to August 2018) who received RT following surgical resection. Time interval (≤22 and >22 days) from surgical resection to initiation of RT and any potential impact on patient outcomes were assessed.
Patients who underwent RT >22 days after surgical resection had a decreased risk for all-cause mortality of 47.2% (95% CI: 8.60, 69.5%). Additionally, waiting >40 days for RT after surgical resection more than doubled the risk of tumor progression; adjusted hazard ratio 2.02 (95% CI: 1.12, 3.64).
Findings indicate that a short interval delay (>22 days) following surgical resection is required before RT initiation for optimal treatment effects in brain metastasis. Our timing of RT postsurgical resection data adds definition to current heterogeneity in RT timing, which is especially important for standardized clinical trial design and patient outcomes.
越来越多的证据支持,为获得最佳反应,在手术后开始放射治疗(RT)前需要短暂延迟。RT开始的时机及其对结局的影响已在多种恶性肿瘤中进行了评估,但脑转移瘤的这种关系仍有待充分确立。
对一家机构(2009年3月至2018年8月)176例年龄在18至89岁之间、接受手术切除后进行RT的脑转移瘤患者进行回顾性研究。评估从手术切除到开始RT的时间间隔(≤22天和>22天)以及对患者结局的任何潜在影响。
手术切除后>22天接受RT的患者全因死亡率风险降低了47.2%(95%CI:8.60,69.5%)。此外,手术切除后等待>40天进行RT使肿瘤进展风险增加了一倍多;调整后的风险比为2.02(95%CI:1.12,3.64)。
研究结果表明,在脑转移瘤中,为获得最佳治疗效果,RT开始前手术切除后需要短暂延迟(>22天)。我们关于手术切除后RT时机的数据为当前RT时机的异质性提供了明确界定,这对标准化临床试验设计和患者结局尤为重要。